💉 Lupin recruits from the US FDA; Novartis to build capability in KSA; Regeneron pays Sanofi to break up; The Kable celebrates #100

RA drugs might reduce Covid deaths

You are reading our hundredth Kable – the centennial edition of this 3-month old infant of a newsletter. It’s a milestone we are inordinately proud of. We hope you’re proud of us, too and that we’re making a difference in your life. Because YOU are at the forefront of everything we do at The Kable. Our every action is guided by a singular pov – how do w…